Role of Adrenoceptors in Diphenylhydantoin-Stimulated Renin Release

P. Cadnapaphornchai,D. Kellner,F. Mcdonald
DOI: https://doi.org/10.3181/00379727-190-42870
1989-04-01
Abstract:Abstract We have previously shown that diphenylhydantoin (DPH)-stimulated renin release is mediated by, or requires the presence of, the renal nerves. In the present study, we examined the effects of adrenergic blockers in DPH-stimulated renin release in five groups of anesthetized dogs. In vehicle-treated dogs, DPH at a dose of 0.18 mg/kg-min increased renin secretion rate (RSR) from 56 ± 14 to 269 ± 60 and returned to 84 ± 30 ng of angiotensin (ANG) I/hr-min (P < 0.01, analysis of variance). In metoprolol-treated dogs, DPH produced no significant changes in RSR (90 ± 28 to 144 ± 67 to 100 ± 51 ng of ANG I/hr-min). Likewise, in atenolol-treated dogs, RSR was 34 ± 10 before, 59 ± 15 during, and 23 ± 8 ng of ANG I/hr-min after the infusion of DPH. In contrast, after pretreatment with ICI 118,551 (a β 2 adrenoceptor antagonist), RSR was 37 ± 9 before, 151 ± 57 during, and 47 ± 12 ng of ANG I/hr-min after the infusion of DPH (P < 0.01). In phentolamine-treated dogs, RSR was 69 ± 20 before, 295 ± 53 during, and 95 ± 17 ng of ANG I/hr-min after the infusion of DPH (P < 0.01). Changes in renal blood flow, renal vascular resistance, and UNaV were in the same directions in all groups. These data suggest that DPH-stimulated renin release is mediated by β 1 adrenoceptors since both β 2 and α adrenoceptor antagonists have no effects on DPH-stimulated renin release.
What problem does this paper attempt to address?